Customer Center

Samyang News

Samyang News
Samyang Biopharm Participates in ”Arab Health 2019” Print
Affiliates Samyang Biopharm Writer administrator Hits 512 Date 2019.02.18

 

 

Samyang Biopharmaceutical Corp. partook in "Arab Health", which is the largest medical exhibition and conferences in the Middle East, from January 28 to 31. At the exhibition, Samyang Biopharm showcased its products, including surgical sutures such as Trisorb, Neosorb, Monosorb, Monofast, anti-bacterial sutures, and wound management products such as SurgiGuard, ORC hemostasis

 

During the event, Samyang Biopharm enjoyed the opportunity to meet with new overseas customers and deepen the understanding of the global market trends in the industry.

 

Particularly, on the first day of the exhibition, Yun Kim, Chairman and CEO of Samyang Holdings Corp.- which is the holding company of Samyang Biopharm- paid a visit to Samyang Biopharm’s booth to encourage the employees and stressed the significance of developing global business opportunities through international exposure of the company.

 

이전 다음글 제목을 나타낸 표
Prev Yangyoung·Sudang Foundation Holds 2019 Scholarship Ceremony 2019.02.25
Next Samyang Group Awarded the ‘Main Prize’ at German ‘iF Design Award 2019’ 2019.02.14